Emerald Coast Cruisin'

This was quite the impressive event.  Over 3000 classic cars and rat-rods were in town last week.  Our dear friend, Donn gave us VIP Tickets for this event.  Free entry and preferred parking.

We strolled around the event on Friday afternoon and looked at cars.  These pictures were taken then.  When we headed back on Saturday, we were alarmed to see Back Beach Road literally STOPPED with cars waiting to pull in.  We blew it off.  At 10 bucks per person per day, and 3 dollar parking per car, they made a BUNDLE.  Thanks again, Donn.... you saved us money, honey!

Saturday night, we strolled over to Pineapple Willy's http://www.pwillys.com/  via Coyote Ugly Saloon and Dee's Hangout.  They were hosting the FIRE SHOOTING CONTEST.  Unfortunately, my camera batteries died, but it was alot of fun...

Emerald Coast Cruizin

Dee's Hangout Does it Again!

The gang at Dee's Hangout never fail to blow us away with their food and service.  This has turned into our favorite joint on the beach.

Whether it's po-boys, baked oysters, burgers or plates, this is our MUST STOP place.

Went in a couple of nights last week.  Wanted to share pictures of their JALAPENO BAKED OYSTERS....  delicious!   Washed 'em down with ice cold pints of beer for only a BUCK!
Visit Dee's on Facebook

Check out Dee's Menu

Pier Park on Veteran's Day..... Nice Job!

We were in town for the Emerald Coast Cruisin' event, and took a drive through Pier Park on Friday.  They truly outdid themselves this year!  I don't know if I've ever seen so many flags before.  Just lovely.

Pier Park has it all.... retail, restaurants, bars.... the works.  Also beautiful landscaping.  Huge place that runs between Front Beach and Middle Beach roads.

Trip Advisor Link

Pier Park Directory

Novel Therapies Put Multiple Myeloma 'On the Ropes'

SAN FRANCISCO – A sweep of new agents are poised to deliver what could be a knock-out blow to multiple myeloma, according to the director of the myeloma program at the University of California, San Francisco.

Some are second- or third-generation agents in a mainstay class that appear to have less toxicity than and/or overcome resistance to their predecessors, Dr. Jeffrey L. Wolf said at the annual Oncology Congress here. Others come from classes not previously used in this disease. 

"There is a rush to develop new drugs in myeloma," Dr. Wolf told attendees. "We [understand] some mechanisms that the disease seems to favor, so we can interfere with those."

The prospects, in turn, are excellent: "We have made such tremendous headway in myeloma, except for those exceptional cases with 17p deletions and some other adverse prognostic features," he said. "As a disease, it seems to be on the ropes." 

More After the Jump

Multiple Myeloma: Challenges and Progress

 This story is a bit of a downer, but has a nice ending:

“Hopefully, the impressive response rates being reported are durable and will translate into meaningful and long term improvement in survival if not yet cure,” Dingle and Rajkumar concluded.
Link to Entire Story